Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • Data Center
    • Data Center Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Providers
May 22, 2013 01:00 AM

Harkin aims to fast-track legislation on compounding pharmacies, drug tracking

Rich Daly
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Harkin

    A senior Senate Democrat aims to expedite legislation that would establish both a track-and-trace system for drugs and a new regulatory framework for compounding pharmacies.

    Sen. Tom Harkin (D-Iowa), chairman of the Health, Education, Labor and Pensions Committee, told Modern Healthcare that he is pushing for the full Senate to vote in June on the combined legislation after his panel gave it unanimous approval Wednesday. A Harkin spokeswoman contacted Modern Healthcare later and said a July vote is more likely.

    Before passage, the committee voted to combine the Pharmaceutical Compounding Quality and Accountability Act and the Drug Supply Chain Security Act.

    The compounding bill, which was endorsed by some hospitals groups, followed the nationwide outbreak of fungal infections stemming from contaminated drug treatments compounded by the New England Compounding Center. Senators blamed the incident, which was linked to 741 cases of fungal infections and 55 deaths—as of May 6—on a lack of regulatory oversight at the state level.

    The compounding bill's passage came on the same day the committee released a bipartisan report that found a “shocking failure to act” by regulators or legislators, said Sen. Pat Roberts (R-Kan.) (PDF). He and others were critical of Congress for failing to advance a compounding oversight measure for the past 10 years, despite evidence of deaths and serious injuries linked to compounding pharmacies since at least 2001, as chronicled in the report.

    Related Content

    Bad medicine

    The compounding legislation would give the Food and Drug Administration regulatory authority over pharmacies that mix sterile drugs without a prescription and sell those drugs across state lines. Such “compounding manufacturers” would have to register with the FDA, inform the agency about drugs they develop, investigate and report adverse events, and include a label that indicates the drugs were compounded.

    Hospital advocates pushed for an exemption that was included in the bill and would allow state regulation to continue for health systems that share sterile products among their hospitals, such as systems with hospitals in more than one state.

    “In addition, the purpose of compounding carried out by hospital and health system pharmacies is to address the need of identifiable patients pursuant to a prescription order, which is the fundamental distinction between traditional compounders and compounding manufacturers,” Blair Childs, a senior vice president at Premier healthcare alliance, wrote the committee on May 20.

    The exemption drew the ire of compounding advocates. The International Academy of Compounding Pharmacies was concerned that the bill would eliminate safety assurances for hospital patients and create some confusion between federal and state-level regulators, according to a spokesman for the group.

    Committee members said the legislation may need further tweaks before the full Senate votes on it. For instance, Sen. Johnny Isakson (R-Ga.) said he was working on regulatory waivers for home infusion therapy and “partial compounding” used in ophthalmology.

    “I don't want to see the unintended consequence of this lead people into hospitalization when home healthcare therapy and home infusion therapy could be possible, as well,” Isakson said.

    The compounding bill was amended to add a previously separate measure creating a track-and-trace system for pharmaceuticals down to the unit level. The drug tracking legislation broke a years-long log jam among healthcare industry groups over efforts to more closely monitor the nation's drug supply amid growing concerns over threats posed by theft and counterfeit or substandard drugs. Those concerns of drug-supply problems included last year's FDA notification of up to 500 U.S. medical practices that they may have purchased counterfeit versions of a cancer drug.

    The industry-brokered agreement, on which the bill was based, included a 10-year phase-in period for a national system to replace state regulation of drug supply chains in their regions. Previous proposals for shorter start times for a national system had drawn hospital opposition over concerns that providers would face penalties for timeframes they could not meet.

    Sen. Richard Burr (R-N.C.) said the bill established a “workable pathway” to unit-level tracing, while giving providers “critical regulatory certainty.” Burr and others criticized the “patchwork” of state tracking requirements were driving up healthcare costs among healthcare companies operating in multiple states.

    Separate draft legislation on track-and-trace and drug compounding by House Republicans also have begun to circulate, and leaders there also have described their passage as a priority.

    Follow Rich Daly on Twitter: @MHrdaly

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    20160830_Mike_Pykosz_mm0146(1).jpg
    Q&A: Oak Street Health CEO on growth plans after CVS Health deal
    Rapid growth predicted for hospital-at-home market
    Rapid growth predicted for hospital-at-home market
    Most Popular
    1
    More healthcare organizations at risk of credit default, Moody's says
    2
    Centene fills out senior executive team with new president, COO
    3
    SCAN, CareOregon plan to merge into the HealthRight Group
    4
    Blue Cross Blue Shield of Michigan unveils big push that lets physicians take on risk, reap rewards
    5
    Bright Health weighs reverse stock split as delisting looms
    Sponsored Content
    Modern Healthcare A.M. Newsletter: Sign up to receive a comprehensive weekday morning newsletter designed for busy healthcare executives who need the latest and most important healthcare news and analysis.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • Data Center
      • Data Center Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing